Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Low Dose Evaluation on Morphine Consumption in Traumatic Patients
2023-510016-39-00Phase 3Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polytrauma comparing Low-dose ketamine adjunct arm with Placebo ketamine adjunct arm (2 arms). Primary endpoint: Total dose of sufentanil administered at 48 hours. Started Jul 2024; status: completed.
02
Drugs
ketamine
03
Conditions
polytrauma
Beyond the preview
Go deeper on 2023-510016-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510016-39-00.